Researchers caution that popular chatbots, while having the potential to improve access and quality of patient education, provide unreliable medical advice.
A majority of consumer artificial intelligence tools provided inaccurate responses and showed bias, according to a poster presented at the American Academy of Ophthalmology 2023 annual meeting.
Michael Oca
Researchers, led by Michael Oca, an M.D., candidate at the University of California, San Diego, School of Medicine in La Jolla, Calif., assess the responses to common patient questions provided by ChatGPT, Google Bard, and Bing Chat. They then evaluated the information on a scale of 1 to 4 for accuracy.
All three platforms provided high rates of inaccurate recommendations. Chatbot ratings for answering patient questions varied, with Bing Chat (Creative) have the highest score and Bing Chat (Concise) having the lowest score. For creating patient resources, Bing Chat (Creative) received the high score and Bing Chat (Balanced received the lowest rating. Google Bard provide a more consistent quality to prompts.
Researchers also asked the chatbots to recommend four ophthalmologists in 20 U.S. cities. They found that Bing Chat and Bard recommended fewer female ophthalmologists than the national average of 27.2%. Bing Chat recommended just 1.51.% and Bard recommended just 8% female ophthalmologists. ChatGPT also recommended female doctors, but this was not statistically significant.
“Given the substantial bias and inaccuracy demonstrated in this study, we warn against reliance on AI chatbots when seeking health-related information until improvements in algorithms are achieved and validated in the future,” Oca said in a press release.
The authors caution that these models are not fine-tuned to provide accurate eye health information.
Earlier this year, the American Medical Association also cautioned about misleading medical information from AI. At a meeting of AMA House of Delegate, the AMA was directed work with organizations to protect patients from false or misleading AI-generated medical advice.
PHOTON Study of 8-mg Eylea Suggests Some Patients Could Be Treated Just Two Times a Year | AAO 2023
November 5th 2023Approximately one-third of the patients assigned to 16-week intervals of 8-mg formulation of Eylea changed to a 24-week interval during the second year of. the study, according results presented at the annual meeting of the American Academy of Ophthalmology. The PHOTON study enrolled people with diabetic macular edema.
Read More
Teleophthalmology: One Way To Help Span the Healthcare Disparity Divide | AAO 2023
November 5th 2023Albert S. Khouri, M.D., a professor of ophthalmology at the Rutgers New Jersey Medical School, discusses teleophthalmology’s role in outreach efforts and improving ophthalmic care in the emergency room.
Read More